Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Scharl

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Praxis|February 13, 2014
[Therapy of chronic inflammatory bowel diseases: what comes next?]Michael Scharl
Innere Medizin (Heidelberg, Germany)|February 13, 2023
[Which microbiota-based therapies have proven to be effective today?]Michael Scharl
Therapeutische Umschau. Revue Therapeutique|February 1, 2019
[Perianal fistulas in CED: from mouse model to clinic]Michael Scharl
Case Reports in Gastroenterology|June 20, 2017
A Symptomatic Coffee Bean: Acute Sigmoid VolvulusMichael Scharl, Luc Biedermann
Visceral Medicine|February 5, 2024
Microbiota Therapy: Ready for Clinical Practice?Michael Scharl, Gerhard Rogler
Deutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Microbiome: from pathophysiology to clinical application?]Michael Scharl, Gerhard Rogler
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Inflammatory bowel disease: dysfunction of autophagy?Michael Scharl, Gerhard Rogler
Current Opinion in Gastroenterology|May 11, 2012
Inflammatory bowel disease pathogenesis: what is new?Michael Scharl, Gerhard Rogler
Swiss Medical Weekly|November 1, 2018
Genetics and epigenetics of inflammatory bowel diseaseMarcin Wawrzyniak, Michael Scharl
World Journal of Gastrointestinal Pathophysiology|August 19, 2014
Pathophysiology of fistula formation in Crohn's diseaseMichael Scharl, Gerhard Rogler
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Praxis|February 13, 2014
[Therapy of chronic inflammatory bowel diseases: what comes next?]Michael Scharl
Innere Medizin (Heidelberg, Germany)|February 13, 2023
[Which microbiota-based therapies have proven to be effective today?]Michael Scharl
Therapeutische Umschau. Revue Therapeutique|February 1, 2019
[Perianal fistulas in CED: from mouse model to clinic]Michael Scharl
Case Reports in Gastroenterology|June 20, 2017
A Symptomatic Coffee Bean: Acute Sigmoid VolvulusMichael Scharl, Luc Biedermann
Visceral Medicine|February 5, 2024
Microbiota Therapy: Ready for Clinical Practice?Michael Scharl, Gerhard Rogler
Deutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Microbiome: from pathophysiology to clinical application?]Michael Scharl, Gerhard Rogler
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Inflammatory bowel disease: dysfunction of autophagy?Michael Scharl, Gerhard Rogler
Current Opinion in Gastroenterology|May 11, 2012
Inflammatory bowel disease pathogenesis: what is new?Michael Scharl, Gerhard Rogler
Swiss Medical Weekly|November 1, 2018
Genetics and epigenetics of inflammatory bowel diseaseMarcin Wawrzyniak, Michael Scharl
World Journal of Gastrointestinal Pathophysiology|August 19, 2014
Pathophysiology of fistula formation in Crohn's diseaseMichael Scharl, Gerhard Rogler
Pageof 26